retatrutide peptide better than tirzepatide Curious about the differences between today's most popular GLP-1 medications? Here's your quick guide to semaglutide, tirzepatide, and — three powerful tools on the journey toward weight loss, metabolic balance, and Retatrutide vs Tirzepatide: Key Differences
Description
Tirzepatide is a dual GIP and GLP-1 receptor agonist used for type 2 diabetes and weight management, not an immunosuppressive medication

Mounjaros active ingredient, tirzepatide, is known to target both GLP-1 and GIP receptors, which seems to be more effective than Ozempics active ingredient (semiglutide), which only targets GLP-1 receptors, great for certain conditions

Depth: The needle should penetrate through the skin and into the subcutaneous fat layer, which sits between the skin and the muscle

Glucose & Insulin Response Combined GLP-1 and GIP activity improves insulin sensitivity and glucose-dependent insulin release, addressing the metabolic root rather than calories alone

Prediabetes is a condition where blood glucose levels are higher than normal, but not yet high enough to be classified as type 2 diabetes
